| Code | 0774F | ||||||||||
| MA number | 09/0263/25-S | ||||||||||
| Product Form: | plv ino 50x40 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.08.2025 |
| Validity: | 16.08.2030 |
| SPC: |
SPC_Pantoprazol STADA 40 mg prášok na injekčný roztok_plv ino_07/2025_REG.pdf
|
| PIL: |
PIL_Pantoprazol STADA 40 mg prášok na injekčný roztok_plv ino_07/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 26.08.2025 |
